We are excited that you are interested in this new study for adults living with episodic or chronic migraine.

This research is being funded by a grant (#5UH3FD006795-04) from the United States Food and Drug Administration (FDA). The grant, entitled Migraine Clinical Outcome Assessment System, was awarded to Vector Psychometric Group, LLC and Albert Einstein College of Medicine. The goal of this phase of the study is to improve a draft questionnaire that measures migraine experiences. 

We have teamed up with CHAMP, a headache/migraine patient advocacy group, to complete the current phase of the study.

To see if you are eligible for this study, please select “Begin” below.

Please note that the entire screening and enrollment process takes about 30 minutes and must be completed in one sitting.